Prostate Active Surveillance Study
NCT00756665
This study is recruiting at 10 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prostatic Neoplasms
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 21 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- University of Washington
- Last updated on ClinicalTrials.gov
- September 2, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 3
- University of California, San Francisco · San Francisco, CA
- Veterans Affairs San Francisco Health Care System · San Francisco, CA
- Stanford University · Stanford, CA
Georgia · 1
- Emory University · Atlanta, GA
Massachusetts · 1
- Beth Israel Deaconess Medical Center/Harvard Medical School · Boston, MA
Michigan · 1
- University of Michigan · Ann Arbor, MI
Texas · 1
- University of Texas Health Science Center, San Antonio · San Antonio, TX
Virginia · 1
- Eastern Virginia Medical School · Norfolk, VA
Washington · 2
- University of Washington · Seattle, WA
- Veterans Affairs Puget Sound Health Care System · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.